{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:42:13Z","timestamp":1777099333879,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571515"],"award-info":[{"award-number":["81571515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570369"],"award-info":[{"award-number":["81570369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602817"],"award-info":[{"award-number":["81602817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Changjiang Scholars and Innovative Research Team in University","award":["IRT0935"],"award-info":[{"award-number":["IRT0935"]}]},{"name":"Science -technology Support Plan Projects in Sichuan province","award":["2016FZ0088"],"award-info":[{"award-number":["2016FZ0088"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.placenta.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T06:36:16Z","timestamp":1479882976000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines"],"prefix":"10.1016","volume":"49","author":[{"given":"Hongyu","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-7653","authenticated-orcid":false,"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.placenta.2016.11.011_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1471-0528.2006.00927.x","article-title":"Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in The Netherlands","volume":"113","author":"Bakker","year":"2006","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.placenta.2016.11.011_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2165\/11532330-000000000-00000","article-title":"Drugs dispensed in primary care during pregnancy:A record-linkage analysis in Tayside, Scotland","volume":"33","author":"Irvine","year":"2010","journal-title":"Drug Saf."},{"issue":"8","key":"10.1016\/j.placenta.2016.11.011_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pds.1241","article-title":"National patterns of medication use during pregnancy","volume":"15","author":"Lee","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"10.1016\/j.placenta.2016.11.011_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"Staud","year":"2012","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.placenta.2016.11.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.placenta.2016.11.011_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"Smit","year":"1999","journal-title":"J.\u00a0Clin. Invest"},{"issue":"4","key":"10.1016\/j.placenta.2016.11.011_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/mol.59.4.806","article-title":"P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir","volume":"59","author":"Huisman","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.placenta.2016.11.011_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tiv.2009.10.005","article-title":"Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models","volume":"24","author":"Beghin","year":"2010","journal-title":"Toxicol. inVitro"},{"issue":"3","key":"10.1016\/j.placenta.2016.11.011_bib9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.ijcard.2014.07.147","article-title":"Sodium tanshinone IIA sulfonate and sodium danshensu open the placental barrier through down-regulation of placental P-glycoprotein in mice: implications in the transplacental digoxin treatment for fetal heart failure","volume":"176","author":"Wang","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.placenta.2016.11.011_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.placenta.2015.08.007","article-title":"The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: implications in the individualized transplacental digoxin treatment for fetal heart failure","volume":"36","author":"Wang","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2016.11.011_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.maturitas.2016.01.008","article-title":"In utero exposure to carcinogens: epigenetics, developmental disruption and consequences in later life","volume":"86","author":"Waring","year":"2016","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.placenta.2016.11.011_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.siny.2013.05.003","article-title":"Environmental origins of congenital heart disease: the heart-placenta connection","volume":"18","author":"Huhta","year":"2013","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.placenta.2016.11.011_bib13","first-page":"533","article-title":"Regulation of drug transporter expression and function in the placenta","volume":"11","author":"Staud","year":"2015","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.placenta.2016.11.011_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pharmthera.2014.02.012","article-title":"Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases","volume":"143","author":"Eom","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.placenta.2016.11.011_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.placenta.2016.11.011_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/BST20130010","article-title":"The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts","volume":"41","author":"Jamaladdina","year":"2013","journal-title":"Bio Soc. Trans."},{"issue":"11","key":"10.1016\/j.placenta.2016.11.011_bib17","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","article-title":"Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression","volume":"21","author":"Lagger","year":"2002","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.placenta.2016.11.011_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/nar\/gkl048","article-title":"Histone deacetylase 3 binds to and regulates the GCMa transcription factor","volume":"34","author":"Chuang","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.placenta.2016.11.011_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5483\/BMBRep.2014.47.6.169","article-title":"Nuclear localization signal domain of HDAC3 is necessary and sufficient for the expression regulation of MDR1","volume":"47","author":"Park","year":"2014","journal-title":"BMB Rep."},{"issue":"3","key":"10.1016\/j.placenta.2016.11.011_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yexcr.2011.11.010","article-title":"Role for Class I histone deacetylases in multidrug resistance","volume":"318","author":"Xu","year":"2012","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.placenta.2016.11.011_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1541-7786.MCR-08-0296","article-title":"Histone deacetylase inhibitor induction of P-Glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT\/enhancer binding protein \u03b2and pCAF to the promoter region","volume":"7","author":"Kim","year":"2009","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.placenta.2016.11.011_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.02.045","article-title":"The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review","volume":"562","author":"Vahid","year":"2015","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.placenta.2016.11.011_bib23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/mrd.20734","article-title":"The role of multiple drug resistance proteins in fetal and\/or placental protection against teratogen-induced orofacial clefting","volume":"74","author":"Rawles","year":"2007","journal-title":"Mol. Reprod. Dev."},{"issue":"4","key":"10.1016\/j.placenta.2016.11.011_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"1998","journal-title":"Reprod. Toxicol."},{"issue":"7","key":"10.1016\/j.placenta.2016.11.011_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40264-015-0299-3","article-title":"P-Glycoprotein-Mediated drug interactions in pregnancy and changes in the risk of congenital anomalies: a case-reference study","volume":"38","author":"Daud","year":"2015","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.placenta.2016.11.011_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"M1","year":"2012","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2016.11.011_bib27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00246-014-0906-6","article-title":"Maternal medication use, fetal 3435 C>T polymorphism of the ABCB1 gene, and risk ofIsolated septal defects in a Han Chinese population","volume":"35","author":"Wang","year":"2014","journal-title":"Pediatr. Cardiol."},{"issue":"5","key":"10.1016\/j.placenta.2016.11.011_bib28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00246-015-1116-6","article-title":"Parental occupational exposures to endocrine disruptors and the risk of simple isolated congenital heart defects","volume":"36","author":"Wang","year":"2015","journal-title":"Pediatr. Cardiol."},{"issue":"7","key":"10.1016\/j.placenta.2016.11.011_bib29","doi-asserted-by":"crossref","first-page":"e68807","DOI":"10.1371\/journal.pone.0068807","article-title":"Increased risk for congenital heart defects in children carrying the ABCB1 gene C3435T polymorphism and maternal periconceptional toxicants exposure","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.placenta.2016.11.011_bib30","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","article-title":"Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors","volume":"19","author":"Bradbury","year":"2005","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.placenta.2016.11.011_bib31","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone decetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kr\u00e4mer","year":"2003","journal-title":"Embo J."},{"issue":"1","key":"10.1016\/j.placenta.2016.11.011_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.addr.2008.08.008","article-title":"Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation[J]","volume":"61","author":"Wakabayashi-Nakao","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.placenta.2016.11.011_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.placenta.2016.11.011_bib34","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/MCB.18.7.4377","article-title":"Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y","volume":"18","author":"Jin","year":"1998","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.placenta.2016.11.011_bib35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.placenta.2010.08.008","article-title":"Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development","volume":"31","author":"Patel","year":"2010","journal-title":"Placenta"},{"issue":"9","key":"10.1016\/j.placenta.2016.11.011_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.placenta.2013.05.010","article-title":"Effect of oxygen on multidrug resistance in the first trimester human placenta","volume":"34","author":"Lye","year":"2013","journal-title":"Placenta"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400416306415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400416306415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:53:58Z","timestamp":1758909238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400416306415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":36,"alternative-id":["S0143400416306415"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2016.11.011","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}